MedTrace Logo

Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

NCT06288282 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-06-12

No results posted yet for this study

Summary

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Conditions

  • Chronic Back Pain

Interventions

OTHER

No Intervention

No intervention will be used.

Sponsors & Collaborators

Principal Investigators

  • Chinwe Nwaneshiudu · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-20
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06288282 on ClinicalTrials.gov